A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling

Summary

This is a Phase I, open-label, single-dose, 1-period study to compare EDG-5506 concentrations measured from venous and capillary blood sampling in healthy adult subjects. EDG-5506 is an investigational product designed to selectively modulate a fast skeletal muscle motor protein called myosin that is part of the contraction machinery of the damage-prone muscle fibers.

Timeline

Start

2022-08-12

Primary completion

2022-08-19

Completion

2022-08-19

Drugs

Indications